4baseCare Bags ₹38 Cr To Close Series B Round At ₹128 Cr

Months after raising ₹90 Cr, healthtech startup 4baseCare has now secured an additional ₹38 Cr (nearly $4 Mn) to finally close its Series B round at ₹128 Cr ($13 Mn). The latest infusion was led by growX Ventures, with participation from undisclosed existing investors. 

In a statement, the startup said that it plans to continue deploying the freshly raised funds to fuel the expansion of its genomics laboratory network across India, the Middle East, Southeast Asia, Latin America, and Central Asia. A portion of the capital will also be utilised to scale its AI-driven precision oncology platform, OncoTwin.

“… The additional capital will help us expand our genomics lab network globally and further scale OncoTwin, our AI-based precision oncology platform, to support clinicians with deeper, real-world, clinically actionable insights,” said 4baseCare cofounder and CEO Hitesh Goswami.

Founded in 2018 by Goswami and Kshitij Rishi, 4baseCare leverages advanced genomics, bioinformatics, and AI to develop personalised oncology (cancer-related) care for patients. The startup also creates databases that combine genomic data with clinical, environmental, and lifestyle information to enhance precision medicine.

This comes six months after the healthtech startup raised ₹90 Cr in its Series B round co-led by ace investors Ashish Kacholia and Lashit Sanghvi. Prior to this, the Bengaluru-based startup also raised ₹50 Cr in a Series A round led by Yali Capital in 2024. 

The fundraise comes as investors continue to double down on healthtech in India. Buoyed by the rise of AI, many players in the space are pivoting from episodic care to longevity, prevention, and continuous health optimisation. Many of these new-age tech companies are also focussing on health and wellness through wearables and full-stack platforms. 

As a result, investor interest continues to trickle into the sector. Last month, StrainX Bioworks raised $13 Mn in a funding round led by Prime Venture Partners and Leo Capital. In March, Practo cofounder and CEO Shashank ND’s new healthtech venture Cent also raised $5 Mn in a seed round from OneFlow Holdings and South Park Commons. 

In January this year, longevity-focussed healthtech startup Biopeak bagged $2.7 Mn in a round led by Nikhil Kamath’s investment firm NKSquared.

As per Inc42 data, the Indian healthtech market is projected to become a $37 Bn opportunity by 2030.

The post 4baseCare Bags ₹38 Cr To Close Series B Round At ₹128 Cr appeared first on Inc42 Media.